107 related articles for article (PubMed ID: 7767777)
21. PIK3CA and TFRC located in 3q are new prognostic factors in esophageal squamous cell carcinoma.
Wada S; Noguchi T; Takeno S; Kawahara K
Ann Surg Oncol; 2006 Jul; 13(7):961-6. PubMed ID: 16788758
[TBL] [Abstract][Full Text] [Related]
22. Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information.
Shinozaki H; Ozawa S; Ando N; Tsuruta H; Terada M; Ueda M; Kitajima M
Clin Cancer Res; 1996 Jul; 2(7):1155-61. PubMed ID: 9816282
[TBL] [Abstract][Full Text] [Related]
23. Identification and validation of DNA methylation markers to predict lymph node metastasis of esophageal squamous cell carcinomas.
Gyobu K; Yamashita S; Matsuda Y; Igaki H; Niwa T; Oka D; Kushima R; Osugi H; Lee S; Suehiro S; Ushijima T
Ann Surg Oncol; 2011 Apr; 18(4):1185-94. PubMed ID: 21042947
[TBL] [Abstract][Full Text] [Related]
24. [Characteristics of lymph node metastasis of squamous cell carcinoma of thoracic esophagus and its clinical significance].
Wang Y; Wang L; Zhang D
Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):241-3. PubMed ID: 11778241
[TBL] [Abstract][Full Text] [Related]
25. CpG island methylator phenotype of cell-cycle regulators associated with TNM stage and poor prognosis in patients with oesophageal squamous cell carcinoma.
Ling Y; Huang G; Fan L; Wei L; Zhu J; Liu Y; Zhu C; Zhang C
J Clin Pathol; 2011 Mar; 64(3):246-51. PubMed ID: 21169275
[TBL] [Abstract][Full Text] [Related]
26. Prediction of nodal metastasis by comparative genomic hybridization in biopsy specimens from patients with superficial esophageal squamous cell carcinoma.
Ueno T; Tangoku A; Yoshino S; Abe T; Hayashi H; Toshimitsu H; Hashimoto K; Satoh T; Oga A; Furuya T; Oka M; Sasaki K
Clin Cancer Res; 2003 Nov; 9(14):5137-41. PubMed ID: 14613991
[TBL] [Abstract][Full Text] [Related]
27. [Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Zhang XF; Wang YM; Wang R; Wei LZ; Li Y; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 May; 24(5):513-9. PubMed ID: 15890089
[TBL] [Abstract][Full Text] [Related]
28. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
Ando T; Ishiguro H; Kimura M; Mitsui A; Mori Y; Sugito N; Tomoda K; Mori R; Harada K; Katada T; Ogawa R; Fujii Y; Kuwabara Y
Oncol Rep; 2007 Sep; 18(3):601-9. PubMed ID: 17671707
[TBL] [Abstract][Full Text] [Related]
29. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas.
Bollschweiler E; Baldus SE; Schröder W; Prenzel K; Gutschow C; Schneider PM; Hölscher AH
Endoscopy; 2006 Feb; 38(2):149-56. PubMed ID: 16479422
[TBL] [Abstract][Full Text] [Related]
30. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
Faried A; Faried LS; Usman N; Kato H; Kuwano H
Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152
[TBL] [Abstract][Full Text] [Related]
31. Inactivation of the CDKN2 gene by homozygous deletion and de novo methylation is associated with advanced stage esophageal squamous cell carcinoma.
Maesawa C; Tamura G; Nishizuka S; Ogasawara S; Ishida K; Terashima M; Sakata K; Sato N; Saito K; Satodate R
Cancer Res; 1996 Sep; 56(17):3875-8. PubMed ID: 8752149
[TBL] [Abstract][Full Text] [Related]
32. The clinical significance of Aurora-A/STK15/BTAK expression in human esophageal squamous cell carcinoma.
Tanaka E; Hashimoto Y; Ito T; Okumura T; Kan T; Watanabe G; Imamura M; Inazawa J; Shimada Y
Clin Cancer Res; 2005 Mar; 11(5):1827-34. PubMed ID: 15756006
[TBL] [Abstract][Full Text] [Related]
33. Negative implication of C-MYC as an amplification target in esophageal cancer.
Huang XP; Rong TH; Wang JY; Tang YQ; Li BJ; Xu DR; Zhao MQ; Zhang LJ; Fang Y; Su XD; Liang QW
Cancer Genet Cytogenet; 2006 Feb; 165(1):20-4. PubMed ID: 16490593
[TBL] [Abstract][Full Text] [Related]
34. Microsatellite analysis of the APC gene and immunoexpression of E-cadherin, catenin, and tubulin in esophageal squamous cell carcinoma.
Nair KS; Naidoo R; Chetty R
Hum Pathol; 2006 Feb; 37(2):125-34. PubMed ID: 16426911
[TBL] [Abstract][Full Text] [Related]
35. Expression of p53R2 is related to prognosis in patients with esophageal squamous cell carcinoma.
Okumura H; Natsugoe S; Yokomakura N; Kita Y; Matsumoto M; Uchikado Y; Setoyama T; Owaki T; Ishigami S; Aikou T
Clin Cancer Res; 2006 Jun; 12(12):3740-5. PubMed ID: 16778101
[TBL] [Abstract][Full Text] [Related]
36. Risk factors of lymph node metastasis in T1 esophageal squamous cell carcinoma.
Kim DU; Lee JH; Min BH; Shim SG; Chang DK; Kim YH; Rhee PL; Kim JJ; Rhee JC; Kim KM; Shim YM
J Gastroenterol Hepatol; 2008 Apr; 23(4):619-25. PubMed ID: 18086118
[TBL] [Abstract][Full Text] [Related]
37. Role of survivin gene promoter polymorphism (-31G>C) in susceptibility and survival of esophageal cancer in northern India.
Upadhyay R; Khurana R; Kumar S; Ghoshal UC; Mittal B
Ann Surg Oncol; 2011 Mar; 18(3):880-7. PubMed ID: 20957442
[TBL] [Abstract][Full Text] [Related]
38. Allelic loss in esophageal squamous cell carcinoma patients with and without family history of upper gastrointestinal tract cancer.
Hu N; Roth MJ; Emmert-Buck MR; Tang ZZ; Polymeropolous M; Wang QH; Goldstein AM; Han XY; Dawsey SM; Ding T; Giffen C; Taylor PR
Clin Cancer Res; 1999 Nov; 5(11):3476-82. PubMed ID: 10589761
[TBL] [Abstract][Full Text] [Related]
39. [New prognostic factors in patients with esophageal squamous carcinoma].
Ueda M
Gan To Kagaku Ryoho; 1992 Jan; 19(1):20-5. PubMed ID: 1530906
[TBL] [Abstract][Full Text] [Related]
40. Excision repair cross complementing 3 expression is involved in patient prognosis and tumor progression in esophageal cancer.
Terashita Y; Ishiguro H; Haruki N; Sugiura H; Tanaka T; Kimura M; Shinoda N; Kuwabara Y; Fujii Y
Oncol Rep; 2004 Oct; 12(4):827-31. PubMed ID: 15375507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
